Flunarizine in pharma franchise in Agartala

Flunarizine in PCD pharma franchise in Mizoram

Flunarizine in top pharma company in Nagpur

Flunarizine in pcd pharma supplier in Patna

Flunarizine in phama franchise company in India
Flunarizine in phama distributor in Ghaziabad

Home/Products /flunarizine-10mg-propranolol-40mg-tablet

Flunafeb Plus Tablet

Composition : Flunarizine (10mg) + Propranolol (40mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹102/-

Flunafeb Plus combines Flunarizine (10mg) and Propranolol (40mg), two effective medications used to manage and prevent migraine attacks. This combination enhances the efficacy of each drug by targeting different mechanisms involved in migraines. Flunarizine is a calcium channel blocker that helps reduce the dilation of blood vessels, thus preventing migraines. Propranolol, a beta-blocker, helps in reducing the frequency and severity of migraines by stabilizing blood pressure and calming the nervous system. Together, these active ingredients offer a synergistic approach to migraine prevention and management.

Flunafeb Plus is widely used for the prophylaxis of migraine and the management of certain cardiovascular conditions like hypertension. It helps decrease the intensity and frequency of migraines, improving overall quality of life for patients. This medication can also help manage vertigo (dizziness) and is occasionally used for conditions involving irregular heart rhythms.

The combination of Flunarizine and Propranolol ensures that both vascular and nervous system components contributing to migraine attacks are addressed. While Flunarizine reduces the chances of vasodilation, Propranolol acts on the beta-adrenergic receptors to reduce hyperactivity, contributing to better control of the condition. For patients suffering from chronic migraines or frequent episodes, Flunafeb PR may offer significant relief and preventive benefits.

Read More

About the Product

Flunafeb Plus combines Flunarizine (10mg) and Propranolol (40mg), two effective medications used to manage and prevent migraine attacks. This combination enhances the efficacy of each drug by targeting different mechanisms involved in migraines. Flunarizine is a calcium channel blocker that helps reduce the dilation of blood vessels, thus preventing migraines. Propranolol, a beta-blocker, helps in reducing the frequency and severity of migraines by stabilizing blood pressure and calming the nervous system. Together, these active ingredients offer a synergistic approach to migraine prevention and management.

Flunafeb Plus is widely used for the prophylaxis of migraine and the management of certain cardiovascular conditions like hypertension. It helps decrease the intensity and frequency of migraines, improving overall quality of life for patients. This medication can also help manage vertigo (dizziness) and is occasionally used for conditions involving irregular heart rhythms.

The combination of Flunarizine and Propranolol ensures that both vascular and nervous system components contributing to migraine attacks are addressed. While Flunarizine reduces the chances of vasodilation, Propranolol acts on the beta-adrenergic receptors to reduce hyperactivity, contributing to better control of the condition. For patients suffering from chronic migraines or frequent episodes, Flunafeb PR may offer significant relief and preventive benefits.

Common side effects include dizziness, fatigue, nausea, and sleep disturbances. Serious side effects may include bradycardia (slow heart rate), hypotension (low blood pressure), or depression.

Flunafeb Plus is indicated for the prevention of migraines, as well as for managing hypertension and preventing vertigo

Take Flunafeb Plus exactly as prescribed. Discontinue only under a doctor's supervision, as abrupt cessation may trigger side effects.

Store in a cool, dry place, away from direct sunlight and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation